| This week's sponsor is INC Research. | | | |
Top Stories Monday, October 3, 2016 Allergan, not content with a series of big and small deals throughout the last month, has started October with, you’ve guessed it, another deal. Monday, October 3, 2016 Merrimack will cut nearly a quarter of its workforce as its chief, Robert Mulroy, also announces he will be leaving the company in a major restructuring drive aimed at saving cash. Monday, October 3, 2016 Celgene has bought out Swiss biotech EngMab as the Big Biotech looks to broaden its research arsenal into blood cancers. Monday, October 3, 2016 Carrick Therapeutics has wrapped up a $95 million Series A to fuel its ambition to grow into Europe’s leading oncology company. The startup has persuaded some big names to back its plan, with ARCH Venture Partners and Woodford Investment Management leading the round and a who’s who of academic researchers joining the scientific advisory board. Monday, October 3, 2016 Myovant Sciences and Ra Pharmaceuticals are lining up with IPOs for up to $172.5 million and $86.3 million, respectively. Monday, October 3, 2016 Dermatology pharma LEO has gained the seal of approval for its newly opened Science & Tech Hub in Boston by Her Royal Highness, Crown Princess Mary of Denmark. Saturday, October 1, 2016 AstraZeneca has named David Goldstein as chief adviser to its new genome sequencing drive. The appointment gives a professor known for his work on genetic drivers of responses to hepatitis C drugs and inherited disorders influence over the direction of AstraZeneca’s move to build and make use of a database of 2 million whole genomes. | This week's sponsor is FierceBiotech. | | | FierceBiotech Presents:
A Half Day Executive Summit
Hosted at the Royal Society of Medicine, London
R&D Challenges: A UK Perspective
Cocktail Reception to follow
27 October, 2016
Register Now! |
| | | Japanese scientist Yoshinori Ohsumi has won this year’s Nobel Prize in physiology or medicine for his work about how cells stay healthy by recycling waste. Story After the death of Dale Schenk, Dublin-based Prothena has appointed Gene Kinney as its new president and CEO. Statement New York-based Breast Cancer Research Foundation says it has made a $57 million “commitment to breast cancer research” over the next year. Release | |
|
Resources Presented by: Covance The role of health economic data has never been more important. Presented by: Covance Leading manufacturers increasingly employ stakeholder research early in development to better identify the needs of patients and providers. Presented by: Covance Bill Hanlon, PhD, Vice President, Head of Global Regulatory Affairs, Covance and Scott Thiel, MBA, MT (ASCP) RAC, Associate Director, Navigant Consulting, Inc. discuss tapping into the potential of the mobile health applications and their impact on the drug development, clinical trials and the administration of health care. Presented By: ISR Reports ISR’s Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021 report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what the marketplace will look like in five years. Presented By: ISR Reports ISR’s CRO Quality Benchmarking – Phase II/III Service Providers (8th Edition) report provides a Consumer Reports-style analysis of Phase II/III CRO service quality from hundreds of users who rated 44 Phase II/III CROs across 26 critical dimensions of quality. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! Presented by: Biotech Primer This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. Sponsored by: Veeva Systems Gartner research on short- and long-term strategies for IDMP compliance. Drug Development Boot CampTM 2016 November 16-17, 2016 | Boston, MA FierceBiotech Executive Summit October 27, 2016 | London BioImmersion: In Depth Biotech for the Non-Scientist October 5-7, 2016 | Chicago, IL CBI’s 7th West Coast Compliance Congress November 9-10, 2016 | San Francisco, CA ExL's 7th Clinical Quality Oversight Forum October 17-19, 2016 | Philadelphia, PA AdvaMed 2016: The MedTech Conference in Minneapolis October 17-19, 2016 | Minneapolis, MN Master of Science in Bioinformatics at Northeastern University Fall 2016, Spring 2017 Courses Cannabis-Based Therapies November 30–December 1, 2016 | San Francisco, CA BioNetwork Partnering Summit October 5-7, 2016 | Laguna Niguel, CA Clinical Diagnostics & Research November 2-3, 2016 | 